Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
about
The pentapeptide LQVVR plays a pivotal role in human cystatin C fibrillizationFrom high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease.Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease.Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cellsImmunomodulation for prion and prion-related diseases.Solid-state NMR studies of amyloid fibril structureSequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9.Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells.Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid β and the Asn23 Iowa mutation.TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Aβ.Oxidative stress and mitochondria-mediated cell death mechanisms triggered by the familial Danish dementia ADan amyloidComputational modeling of the relationship between amyloid and disease.In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ proteinAlzheimer's disease and glaucoma: mechanistic similarities and differencesAn elderly male with tingly legs and a heavy heart: Persisting with the diagnosis!"Clicked" sugar-curcumin conjugate: modulator of amyloid-β and tau peptide aggregation at ultralow concentrations.Using chirality to probe the conformational dynamics and assembly of intrinsically disordered amyloid proteins.Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.Benefit of Oleuropein Aglycone for Alzheimer's Disease by Promoting Autophagy.
P2860
Q24308267-8BC90EB8-11B5-4865-B1C7-48720F5F66B6Q31023317-578BD08E-174B-4792-B274-0ABC72695A17Q33725397-FB41C0C9-4B46-4039-BB56-0F6CB9F48B1DQ34094501-03C34F88-DF7F-47CA-8D4B-C82C5C65EE7BQ34565644-740FC19C-2CA3-4A4E-B4C2-7DC5ABF6F391Q35327629-FAD19593-D0E5-47ED-B8D1-CCE199BF8B8EQ35610552-646A7880-9DE8-4636-B7CF-D1628639C302Q35741865-C4CCBF82-D5D2-402D-A92E-7E215D653F47Q35742895-D9410951-6E89-4910-B1E3-BAD403E74E5EQ36071985-AB33CD5A-C4E8-4D81-B45B-A0E43DDC3443Q36396174-60552186-F7F6-40EC-A1EC-41FA608BF7C4Q36677013-667EEB79-00F3-4708-86D1-6DFAA6A39C73Q37284771-582F5D38-43EE-432E-9D6F-DC6DA04517F7Q38111673-BEC3B891-3981-4246-8289-574928CFC435Q39043920-2357BF76-5228-479A-9DD5-8A1EFC761EE5Q41992508-E06C8060-21A3-415B-AC58-D5BD0ED0B4B1Q42286231-72829BD9-4557-409C-8E5B-12D182DF4776Q46335422-881C6983-7B3D-43A5-970E-56DD4FCBFC80Q55260434-69BB0C89-382F-46B1-961B-B1790E74C1E7
P2860
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
@ast
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
@en
type
label
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
@ast
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
@en
prefLabel
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
@ast
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
@en
P2093
P2860
P1476
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes
@en
P2093
P2860
P2888
P304
P356
10.1007/S00018-009-0182-4
P50
P577
2009-11-07T00:00:00Z